David Roofeh
5PUBLICATIONS
43CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 15, 2022
Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohort.Ahmad Ramahi, Alain Lescoat, David Roofeh
|Sep 29, 2022
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.David Roofeh, Kevin K Brown, Ella A Kazerooni
|Apr 06, 2022
Treatment of systemic sclerosis-associated interstitial lung disease: Lessons from clinical trials.David Roofeh, Oliver Distler, Yannick Allanore
|Feb 04, 2021
Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease.David Roofeh, Celia J F Lin, Jonathan Goldin
|Oct 15, 2020
Emerging drugs for the treatment of scleroderma: a review of recent phase 2 and 3 trials.David Roofeh, Alain Lescoat, Dinesh Khanna
Pageof 1
Frequent Collaborators
4 joint publications
Dinesh Khanna
3 joint publications
Christopher P Denton
1 joint publications
Grace Hyun Kim
1 joint publications
Ella A Kazerooni
1 joint publications
Donald Tashkin
1 joint publications
Shervin Assassi
1 joint publications
Fernando Martinez
1 joint publications
Athol U Wells
1 joint publications
Ganesh Raghu
1 joint publications
Lorinda Chung
